From the Right
AllSides Media Bias Rating: Lean Right
The treatment has a list price of £1.6 million and will be offered to people suffering from a genetic blood disorder often resulting from inter-cousin marriage. A treatment using the Crispr gene editing tool has become the first of its kind to be approved for NHS use, to treat patients with a rare, inherited blood disorder often found in those born of inter-cousin marriages. Hundreds of people living in England with a life-limiting blood disorder could be in line to receive the treatment, which has a list price of over...
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Red Blue Translator
Scientific
Red Blue Translator
Anti-Science
Headline Roundup
Pollsters Face Obstacles as 2026 Midterms Approach
November 2nd, 2026
Recommended Reading
Villain or Hero? How the Left and Right Covered the Lone Holdout Juror in the Lindsay Clancy Trial
Jamie Krstev
November 3rd, 2026